Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
about
Added value of QuantiFERON TB-gold in-tube for detecting latent tuberculosis infection among persons living with HIV/AIDS.Economic challenges associated with tuberculosis diagnostic development.Clinical Correlates and Drug Resistance in HIV-Infected and -Uninfected Pulmonary Tuberculosis Patients in South India.BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis.Simultaneous LC-MS-MS Determination of Lopinavir and Rifabutin in Human Plasma.
P2860
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
@en
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
@nl
type
label
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
@en
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
@nl
prefLabel
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
@en
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
@nl
P2860
P1476
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
@en
P2093
Kerry L Dierberg
P2860
P304
P356
10.1016/J.CCM.2013.02.003
P577
2013-04-08T00:00:00Z